Logo_Biofrontera_AG.png
All Biofrontera Management Board members intend to fully accept the partial tender offer by Maruho Deutschland GmbH for their shares
June 21, 2019 03:30 ET | Biofrontera AG
The Management Board intends to tender all personally held Biofrontera AG shares to Maruho Deutschland GmbHThe Management Board intends to help Maruho Deutschland GmbH to successfully complete its...
Logo_Biofrontera_AG.png
Biofrontera Announces Conference Call on May 29, 2019 to Discuss First Quarter 2019 Financial Results
May 16, 2019 04:30 ET | Biofrontera AG
Leverkusen, Germany, May 16, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing its...
LOGO.png
GREATER CANNABIS COMPANY PARTNERS WITH SYMTOMAX® TO EXPAND ACROSS EUROPE, THE MIDDLE EAST AND AFRICA
May 07, 2019 08:30 ET | The Greater Cannabis Company, Inc.
BALTIMORE, MD, May 07, 2019 (GLOBE NEWSWIRE) -- Greater Cannabis Company (OTCQB: GCAN), a market leader and innovator in the development and commercialization of cannabinoid delivery systems, today...
Logo_Biofrontera_AG.png
Biofrontera Reports Full Year 2018 Financial Results
April 29, 2019 02:00 ET | Biofrontera AG
Leverkusen, Germany, April 29, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its...
Logo_Biofrontera_AG.png
Biofrontera AG to hold extraordinary shareholders’ meeting on 15 May 2019
April 26, 2019 09:20 ET | Biofrontera AG
Leverkusen, Germany, April 26, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced in...
Logo_Biofrontera_AG.png
Biofrontera reports further positive results from the phase III trial with Ameluz® for photodynamic therapy of actinic keratoses on the extremities and trunk/neck
April 16, 2019 07:30 ET | Biofrontera AG
Leverkusen, Germany, April 16, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reports...
Logo_Biofrontera_AG.png
Biofrontera Announces Conference Call on April 29, 2019 to Discuss 2018 Financial Results
April 16, 2019 05:30 ET | Biofrontera AG
Leverkusen, Germany, April 16, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, will be releasing...
Logo_Biofrontera_AG.png
Biofrontera reports preliminary unaudited sales revenue for the first three months of 2019
April 15, 2019 06:15 ET | Biofrontera AG
Leverkusen, Germany, April 15, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reports...
Logo_Biofrontera_AG.png
Changes in the composition of the Supervisory Board
March 27, 2019 09:05 ET | Biofrontera AG
Leverkusen, Germany, March 27, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announces that the...
Logo_Biofrontera_AG.png
Biofrontera provides corporate update; conference call details for March 26, 2019
March 25, 2019 11:30 ET | Biofrontera AG
Leverkusen, Germany, March 25, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, announces a...